Literature DB >> 8242923

The integrity of intervertebral disks after operative treatment of thoracolumbar fractures.

M Vornanen1, O Böstman, P Keto, P Myllynen.   

Abstract

This study presents the results of magnetic resonance imaging (MRI) follow-up studies on 14 patients with unstable fractures of T12 or L1. Internal fixation was performed with Harrington rods in eight patients and with transpedicular fixation in six patients. Sixteen intervertebral disks adjacent to the fractured vertebral body in 11 patients showed decreased signal intensity in T2-weighted images. None of the uninjured intervertebral disks showed any detectable signal decrease in T2-weighted images. Temporary fixation of several healthy motion segments of thoracolumbar spine, as is necessary with Harrington instrumentation for 11 months, on average, does not seem to result in an intervertebral disk degeneration detectable on MRI in the patients within a follow-up period of two years.

Entities:  

Mesh:

Year:  1993        PMID: 8242923

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Radiological study on disc degeneration of thoracolumbar burst fractures treated by percutaneous pedicle screw fixation.

Authors:  Jian Wang; Yue Zhou; Zheng Feng Zhang; Chang Qing Li; Wen Jie Zheng; Jie Liu
Journal:  Eur Spine J       Date:  2012-08-14       Impact factor: 3.134

2.  Disc degeneration of pediatric patients in lumbar MRI.

Authors:  S Salo; H Paajanen; A Alanen
Journal:  Pediatr Radiol       Date:  1995

3.  Vertebral endplate trauma induces disc cell apoptosis and promotes organ degeneration in vitro.

Authors:  Daniel Haschtmann; Jivko V Stoyanov; Philippe Gédet; Stephen J Ferguson
Journal:  Eur Spine J       Date:  2007-10-10       Impact factor: 3.134

4.  Mechanical performance of the Dick internal fixator: a clinical study of 75 patients.

Authors:  P M Rommens; F Weyns; F Van Calenbergh; J Goffin; P L Broos
Journal:  Eur Spine J       Date:  1995       Impact factor: 3.134

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.